UBS Group
GPAT

UBS Group’s GP-Act III Acquisition Corp GPAT Stock Holding History

UBS Group’s Portfolio GPAT Stock Details GPAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02K Sell
186
-2,045
-92% -$22K ﹤0.01% 9380
2025
Q4 		$23.8K Sell
2,231
-8,926
-80% -$95.2K ﹤0.01% 7661
2025
Q3 		$118K Buy
11,157
+3,124
+39% +$33K ﹤0.01% 7003
2025
Q2 		$84.7K Buy
8,033
+3,883
+94% +$40.6K ﹤0.01% 7371
2025
Q1 		$42.7K Buy
4,150
+3,750
+938% +$38.4K ﹤0.01% 7699
2024
Q4 		$4.06K Buy
+400
New +$4.04K ﹤0.01% 8794

Other funds holding GPAT

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return

UBS Group's GPAT Position: Q1 2026 in Review

UBS Group reduced its GP-Act III Acquisition Corp (GPAT) stake by 92% in Q1 2026, selling an estimated $22K and leaving 186 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #9380.

UBS Group first reported a position in GPAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $118K in Q3 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • UBS Group held 186 shares of GP-Act III Acquisition Corp worth $2.02K as of Q1 2026.
  • UBS Group sold 2,045 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $22K.
  • GP-Act III Acquisition Corp made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9380 holding.
  • UBS Group first reported a position in GP-Act III Acquisition Corp in Q4 2024 and has held it in 6 quarters since.
  • UBS Group's GP-Act III Acquisition Corp position peaked at $118K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.